GPER1 and breast carcinoma: For instance, it has been demonstrated that ligand-activated GPER triggers EGFR transactivation and subsequent transduction events such as the activation of MAPK and PI3K, gene transcription and biological responses like proliferation, migration and angiogenesis in breast cancer cells and CAFs [45].